Greenwich LifeSciences Inc. (GLSI) NASDAQ

$8.48 0.07 (0.83%)

Market Cap: $110.24M

As of 06/24/22 04:00 PM EDT. Market closed.

(GLSI)

Greenwich LifeSciences Inc. (GLSI) NASDAQ

$8.48 0.07 (0.83%)

Market Cap: $110.24M

As of 06/24/22 04:00 PM EDT. Market closed.

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein. In a randomized, single-blinded, placebo-controlled, multi-center (16 sites led by MD Anderson Cancer Center) Phase IIb ... read more

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein. In a randomized, single-blinded, placebo-controlled, multi-center (16 sites led by MD Anderson Cancer Center) Phase IIb clinical trial, no recurrences were observed in the HER2/neu 3+ adjuvant setting after median 5 years of follow-up, if the patient received the 6 primary intradermal injections over the first 6 months (p = 0.0338). Of the 138 patients that have been treated with GP2 to date over 4 clinical trials, GP2 treatment was well tolerated and no serious adverse events were observed related to GP2 immunotherapy. Greenwich LifeSciences is planning to commence a Phase III clinical trial using a similar treatment regime as the Phase IIb clinical trial. read less

COMPANY PROFILE
Sector
Industry
Sector
Industry
Full Time Employees
2
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$8.65
Previous Close
$8.41
Days Range
$8.37 - $9.57
52 week range
$6.82 - $48.96
Volume
593,378
Avg. Volume (30 days)
263,751
Market Cap
$110.24M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
13,000,357
Open
$8.65
Previous Close
$8.41
Days Range
$8.37 - $9.57
52 week range
$6.82 - $48.96
Volume
593,378
Avg. Volume (30 days)
263,751
Market Cap
$110.24M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
13,000,357

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GREENWICH LIFESCIENCES INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Patel Snehal CEO and CFO Jun 16, 2022 Buy $7.13 8,000 57,040 2,683,886 Jun 17, 2022, 06:05 AM
Patel Snehal CEO and CFO Jun 14, 2022 Buy $7.91 12,000 94,920 2,675,886 Jun 15, 2022, 06:05 AM
Patel Snehal CEO and CFO Jun 10, 2022 Buy $8.33 12,000 99,960 2,663,886 Jun 13, 2022, 06:04 AM
Patel Snehal CEO and CFO Jun 09, 2022 Buy $10.90 4,500 49,050 1,243,453 Jun 10, 2022, 06:05 AM
Patel Snehal CEO and CFO Jun 07, 2022 Buy $8.55 6,000 51,300 1,238,953 Jun 08, 2022, 06:07 AM
Patel Snehal CEO and CFO Jun 03, 2022 Buy $8.35 9,250 77,238 1,232,953 Jun 06, 2022, 06:05 AM
Patel Snehal CEO and CFO Jun 02, 2022 Buy $7.38 6,774 49,992 1,223,703 Jun 03, 2022, 06:05 AM
Daugherty Frank Joseph Chief Medical Officer Apr 25, 2022 Buy $16.25 1,000 16,250 90,121 Apr 26, 2022, 06:05 AM
Patel Snehal CEO and CFO Apr 21, 2022 Buy $16.09 6,000 96,540 1,216,929 Apr 22, 2022, 06:04 AM
Patel Snehal CEO and CFO Apr 19, 2022 Buy $16.74 6,000 100,440 1,210,929 Apr 21, 2022, 06:03 AM
Thompson Jaye VP Clinical Reg Affairs Apr 19, 2022 Buy $16.74 500 8,370 255,995 Apr 20, 2022, 06:02 AM
Patel Snehal CEO and CFO Feb 11, 2022 Buy $19.80 5,500 108,900 1,204,929 Feb 14, 2022, 06:06 AM
Patel Snehal CEO and CFO Feb 04, 2022 Buy $19.59 5,000 97,950 1,199,429 Feb 08, 2022, 06:02 AM
Thompson Jaye VP Clinical Reg Affairs Jan 31, 2022 Buy $18.47 500 9,235 255,495 Feb 01, 2022, 06:01 AM
Thompson Jaye VP Clinical Reg Affairs Jan 21, 2022 Buy $16.33 500 8,165 254,995 Jan 24, 2022, 06:08 AM
Hallock Kenneth Director Jan 21, 2022 Buy $16.32 300 4,896 397,304 Jan 24, 2022, 06:08 AM
Thompson Jaye VP Clinical Reg. Affairs Jan 18, 2022 Buy $18.87 500 9,435 254,495 Jan 19, 2022, 06:09 AM
Patel Snehal CEO and CFO Jan 13, 2022 Buy $19.99 1,000 19,990 1,194,429 Jan 18, 2022, 06:05 AM
Thompson Jaye VP Clinical Reg. Affairs Jan 13, 2022 Buy $19.99 1,000 19,990 253,995 Jan 14, 2022, 06:06 AM
Daugherty Frank Joseph Chief Medical Officer Jan 13, 2022 Buy $19.99 1,000 19,990 89,121 Jan 14, 2022, 06:05 AM
Patel Snehal CEO and CFO Jan 03, 2022 Buy $23.82 2,050 48,831 1,193,429 Jan 04, 2022, 06:05 AM
Patel Snehal CEO and CFO Dec 14, 2021 Buy $27.17 1,840 49,992 1,191,379 Dec 16, 2021, 06:08 AM
Daugherty Frank Joseph Chief Medical Officer Dec 14, 2021 Buy $26.99 1,111 29,983 88,121 Dec 16, 2021, 06:05 AM
McWilliams David Director Dec 14, 2021 Buy $27.56 200 5,512 620,301 Dec 16, 2021, 06:02 AM
Patel Snehal CEO and CFO Apr 13, 2021 Buy $36.98 2,700 99,853 1,189,539 Apr 14, 2021, 07:30 AM
Hallock Kenneth Director Nov 24, 2020 Buy $5.39 1,000 5,386 397,004 Nov 27, 2020, 07:00 AM
Daugherty Frank Joseph Chief Medical Officer Nov 23, 2020 Buy $5.10 1,000 5,100 87,010 Nov 25, 2020, 07:00 AM
McWilliams David Director Nov 20, 2020 Buy $5.40 1,500 8,100 620,101 Nov 24, 2020, 08:00 AM
Hallock Kenneth Director Nov 20, 2020 Buy $5.37 1,000 5,370 396,004 Nov 24, 2020, 08:00 AM
Rothe Eric Director Nov 20, 2020 Buy $5.40 2,000 10,800 313,226 Nov 24, 2020, 08:00 AM
Patel Snehal CEO and CFO Nov 19, 2020 Buy $5.40 2,000 10,795 1,186,839 Nov 20, 2020, 07:00 AM
Patel Snehal CEO and CFO Sep 29, 2020 Buy $4.60 16,667 76,710 1,184,839 Oct 01, 2020, 08:00 AM
Hallock Kenneth Director Sep 29, 2020 Buy $4.60 8,333 38,353 395,004 Oct 01, 2020, 08:00 AM
Hallock Kenneth Director Sep 29, 2020 Buy $5.75 74,782 429,997 257,368 Sep 29, 2020, 09:42 PM
Patel Snehal CEO and CFO Sep 29, 2020 Buy $5.75 114,347 657,495 863,683 Sep 29, 2020, 09:42 PM
Daugherty Frank Joseph Chief Medical Officer Sep 29, 2020 Buy $5.75 1,739 9,999 86,010 Sep 29, 2020, 09:42 PM
McWilliams David Director Sep 29, 2020 Buy $5.75 2,608 14,996 446,979 Sep 29, 2020, 09:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Patel Snehal CEO and CFO 06/16/2022 57,040
Patel Snehal CEO and CFO 06/14/2022 94,920
Patel Snehal CEO and CFO 06/10/2022 99,960
Patel Snehal CEO and CFO 06/09/2022 49,050
Patel Snehal CEO and CFO 06/07/2022 51,300
Patel Snehal CEO and CFO 06/03/2022 77,238
Patel Snehal CEO and CFO 06/02/2022 49,992
Daugherty Frank Joseph Chief Medical Officer 04/25/2022 16,250
Patel Snehal CEO and CFO 04/21/2022 96,540
Patel Snehal CEO and CFO 04/19/2022 100,440
Thompson Jaye VP Clinical Reg Affairs 04/19/2022 8,370
Patel Snehal CEO and CFO 02/11/2022 108,900
Patel Snehal CEO and CFO 02/04/2022 97,950
Thompson Jaye VP Clinical Reg Affairs 01/31/2022 9,235
Thompson Jaye VP Clinical Reg Affairs 01/21/2022 8,165
Hallock Kenneth Director 01/21/2022 4,896
Thompson Jaye VP Clinical Reg. Affairs 01/18/2022 9,435
Patel Snehal CEO and CFO 01/13/2022 19,990
Thompson Jaye VP Clinical Reg. Affairs 01/13/2022 19,990
Daugherty Frank Joseph Chief Medical Officer 01/13/2022 19,990
Patel Snehal CEO and CFO 01/03/2022 48,831
Patel Snehal CEO and CFO 12/14/2021 49,992
Daugherty Frank Joseph Chief Medical Officer 12/14/2021 29,983
McWilliams David Director 12/14/2021 5,512
Patel Snehal CEO and CFO 04/13/2021 99,853
Hallock Kenneth Director 11/24/2020 5,386
Daugherty Frank Joseph Chief Medical Officer 11/23/2020 5,100
McWilliams David Director 11/20/2020 8,100
Hallock Kenneth Director 11/20/2020 5,370
Rothe Eric Director 11/20/2020 10,800
Patel Snehal CEO and CFO 11/19/2020 10,795
Patel Snehal CEO and CFO 09/29/2020 76,710
Hallock Kenneth Director 09/29/2020 38,353
Hallock Kenneth Director 09/29/2020 429,997
Patel Snehal CEO and CFO 09/29/2020 657,495
Daugherty Frank Joseph Chief Medical Officer 09/29/2020 9,999
McWilliams David Director 09/29/2020 14,996
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
0.92%
1Q
12/31/2021
06/30/2021
1.21%
2Q
12/31/2021
03/31/2021
1.12%
3Q
12/31/2021
12/31/2020
36.27%
4Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.92%
1Q
06/30/2021
1.21%
2Q
03/31/2021
1.12%
3Q
12/31/2020
36.27%
4Q
Load More
BUYBACK ANNOUNCEMENT(S)
Date Announced
01/24/2022 (Announcement)
Market Cap at Announcement
$245.40M
Price on Announcement
$18.7
Buyback/Market Cap (%)
4.07%
Buyback Amount
$10M
Buyback Shares
534,759
Buyback Type
New
Repurchase Method
Market Price
Date Announced
01/24/2022 (Announcement)
Market Cap at Announcement
$245.40M
Price on Announcement
$18.7
Buyback/Market Cap (%)
4.07%
Buyback Amount
$10M
Buyback Shares
534,759
Buyback Type
New
Repurchase Method
Market Price